I6125

ヨードアセトアミド

≥99% (NMR), crystalline

• 別名: α-Iodoacetamide, 2-Iodoacetamide
• 化学式: ICH₂CONH₂
• CAS番号: 144-48-9
• 分子量: 184.96
• Beilstein: 1739080
• EC Number: 205-630-1
• MDL番号: MFCD00008028
• UNSPSCコード: 12352202
• PubChem Substance ID: 24896083
• NACRES: NA.77

特性

• 由来生物: synthetic (organic)
• アッセイ: ≥99% (NMR)
• 形状: crystalline
• mp: 92-95 °C (lit.)
• 溶解性: H₂O: soluble 0.5 M, clear, colorless
• 保管温度: 2-8°C
• SMILES記法: NC(=O)CI
• InChI: 1S/C2H4INO/c3-1-2(4)5/h1H2,(H2,4,5)
• InChI Key: PGLTVOMIXTUURA-UHFFFAOYSA-N

詳細

アプリケーション

• A Mass Spectrometry Strategy for Protein Quantification Based on the Differential Alkylation of Cysteines Using Iodoacetamide and Acrylamide.: This study presents a novel mass spectrometry method for quantifying proteins by differentially alkylating cysteines with iodoacetamide and acrylamide, enhancing the accuracy of protein quantification in complex samples. (Virág et al., 2024).


• Laminarin ameliorates iodoacetamide-induced functional dyspepsia via modulation of 5-HT(3) receptors and the gut microbiota.: Research demonstrates that laminarin can mitigate functional dyspepsia induced by iodoacetamide through modulating 5-HT(3) receptors and altering gut microbiota composition, offering potential therapeutic benefits. (Liu et al., 2024).


• Redox proteomics in melanoma cells: An optimized protocol.: This paper describes an optimized redox proteomics protocol using iodoacetamide, which facilitates the identification of redox-sensitive proteins in melanoma cells, aiding in the understanding of redox regulation in cancer. (Cunha et al., 2024).


• Molecular targets of cisplatin in HeLa cells explored through competitive activity-based protein profiling strategy.: Utilizing iodoacetamide in competitive activity-based protein profiling, this study identifies molecular targets of cisplatin in HeLa cells, providing insights into the drug′s mechanisms. (Chen et al., 2024).


• Development and Comparison of 4-Thiouridine to Cytidine Base Conversion Reaction.: This research compares base conversion reactions involving 4-thiouridine and cytidine, with iodoacetamide playing a crucial role in the reaction mechanism, contributing to advancements in nucleotide chemistry. (Ohashi et al., 2024).

生物化学的／生理学的作用

ヨードアセトアミドは、ペプチドシーケンシングにおけるシステイン残基のアルキル化試薬として機能します。活性部位にシステインを有する酵素の不可逆阻害剤です。ヒスチジン残基との反応速度はかなり遅くなりますが、その活性はリボヌクレアーゼの阻害に関与しています。

安全性情報

• ピクトグラム: GHS06,GHS08
• シグナルワード: Danger
• 危険有害性情報: H301,H317,H334,H413
• 注意書き: P261 - P264 - P273 - P280 - P301 + P310 - P302 + P352
• 危険有害性の分類: Acute Tox. 3 Oral - Aquatic Chronic 4 - Resp. Sens. 1 - Skin Sens. 1
• 保管分類コード: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• WGK: WGK 3
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable
• 個人用保護具 (PPE): Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges